# Life Science Tools Sector

Canonical URL: https://biopharmsignal.com/sector/life-science-tools

Life Science Tools is a company sector tag on BioPharmSignal. This page groups public biotech and healthcare companies associated with Life Science Tools, making it easier to scan related businesses, compare peers, and follow companies exposed to the same modality, disease area, or development theme.

Companies currently grouped under Life Science Tools: 12

## Recent Sector News

- 2026-10-08 12:00 EST — TECH — [Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development](https://biopharmsignal.com/news/TECH/bio-techne-expands-global-gmp-manufacturing-network-with-new-bristol-facility-to-be8891a5) — Source: Bio-Techne
- 2026-10-07 12:30 EST — ACHV — [Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-appoints-kaitlyn-tuson-as-senior-vice-president-marketing--82b4a701) — Source: Achieve Life Sciences
- 2026-10-06 20:02 EST — ACHV — [Achieve Life Sciences Announces Granting of New Hire Inducement Awards](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-announces-granting-of-new-hire-inducement-awards-bf1d3282) — Source: Achieve Life Sciences
- 2026-10-06 13:05 EST — RGEN — [Repligen Completes Acquisition of BioLife Solutions](https://biopharmsignal.com/news/RGEN/repligen-completes-acquisition-of-biolife-solutions-0e73cde6) — Source: Repligen
- 2026-10-01 12:30 EST — ACHV — [Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-appoints-benjamin-halladay-as-chief-financial-officer-c0f8ec98) — Source: Achieve Life Sciences
- 2026-10-01 11:30 EST — WVE — [Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD](https://biopharmsignal.com/news/WVE/wave-life-sciences-announces-fda-feedback-supports-registrational-pathway-for-wv-299cc069) — Source: Wave Life Sciences
- 2026-09-30 11:30 EST — WVE — [Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development](https://biopharmsignal.com/news/WVE/wave-life-sciences-announces-gsk-s-selection-of-sirna-program-to-transition-to-g-a0e4d25e) — Source: Wave Life Sciences
- 2026-09-28 12:30 EST — ACHV — [Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-to-present-52-week-cytisinicline-efficacy-data-for-smoking-dc22e7f8) — Source: Achieve Life Sciences
- 2026-09-25 17:00 EST — SLS — [SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer](https://biopharmsignal.com/news/SLS/sellas-life-sciences-presents-preclinical-data-demonstrating-sls009-activity-in--de40fa57) — Source: SELLAS Life Sciences Group, Inc.
- 2026-09-23 13:20 EST — TECH — [Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany](https://biopharmsignal.com/news/TECH/bio-techne-shareholders-approve-acquisition-by-merck-kgaa-darmstadt-germany-6f57b72d) — Source: Bio-Techne
- 2026-09-23 11:30 EST — WVE — [Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity](https://biopharmsignal.com/news/WVE/wave-life-sciences-initiates-phase-2a-combination-trial-of-wve-007-galnac-sirna--72c1552e) — Source: Wave Life Sciences
- 2026-09-22 13:00 EST — TECH — [Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration](https://biopharmsignal.com/news/TECH/bio-techne-opens-new-customer-experience-center-in-d-sseldorf-to-accelerate-scie-1744afb6) — Source: Bio-Techne
- 2026-09-22 11:30 EST — WVE — [Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer](https://biopharmsignal.com/news/WVE/wave-life-sciences-announces-appointment-of-dr-monika-vnuk-as-chief-business-off-5248ae92) — Source: Wave Life Sciences
- 2026-09-04 12:00 EST — AZTA — [Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems](https://biopharmsignal.com/news/AZTA/azenta-receives-full-repayment-of-35-million-vendor-loan-related-to-sale-of-b-me-c544a478) — Source: Azenta Life Sciences
- 2026-09-03 21:15 EST — ACHV — [Achieve Life Sciences Announced Granting of New Hire Inducement Awards](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-announced-granting-of-new-hire-inducement-awards-b7010265) — Source: Achieve Life Sciences
- 2026-09-03 20:05 EST — WVE — [Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference](https://biopharmsignal.com/news/WVE/wave-life-sciences-to-present-at-cantor-2026-global-healthcare-conference-d1a5dd9a) — Source: Wave Life Sciences
- 2026-09-02 12:30 EST — SLS — [SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer](https://biopharmsignal.com/news/SLS/sellas-life-sciences-to-present-preclinical-data-on-sls009-in-pancreatic-ductal--ab9a17c1) — Source: SELLAS Life Sciences Group, Inc.
- 2026-09-01 10:30 EST — TECH — [Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals](https://biopharmsignal.com/news/TECH/bio-techne-achieves-science-based-targets-validation-and-reports-significant-pro-ad3179b7) — Source: Bio-Techne
- 2026-08-26 11:30 EST — RGEN — [Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference](https://biopharmsignal.com/news/RGEN/repligen-corporation-to-present-at-wells-fargo-21st-annual-healthcare-conference-c33c028f) — Source: Repligen
- 2026-08-24 12:00 EST — AZTA — [AZENTA ANNOUNCES LEADERSHIP TRANSITION](https://biopharmsignal.com/news/AZTA/azenta-announces-leadership-transition-a15d0c73) — Source: Azenta Life Sciences

## Companies

- [TXG](https://biopharmsignal.com/company/TXG) — 10x Genomics
- [ATNF](https://biopharmsignal.com/company/ATNF) — 180 Life Sciences
- [MASS](https://biopharmsignal.com/company/MASS) — 908 Devices
- [ACHV](https://biopharmsignal.com/company/ACHV) — Achieve Life Sciences
- [AZTA](https://biopharmsignal.com/company/AZTA) — Azenta Life Sciences
- [TECH](https://biopharmsignal.com/company/TECH) — Bio-Techne
- [KZR](https://biopharmsignal.com/company/KZR) — Kezar Life Sciences
- [RGEN](https://biopharmsignal.com/company/RGEN) — Repligen
- [SLS](https://biopharmsignal.com/company/SLS) — SELLAS Life Sciences Group, Inc.
- [SQL](https://biopharmsignal.com/company/SQL) — SeqLL
- [WAT](https://biopharmsignal.com/company/WAT) — Waters Corporation
- [WVE](https://biopharmsignal.com/company/WVE) — Wave Life Sciences